Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Guillermo Torre Insider Profile
4 Followers
Guillermo Torre, Director at Cardiol Therapeutics, holds 259.31K shares in Cardiol Therapeutics (Ticker: CRDL). Most recently, Guillermo Torre Bought $17,240 shares of Cardiol Therapeutics on Dec 27, 2024 for an estimated value of 21.72K.
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-38.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Guillermo Torre's holdings
Insider Roles
Director
Roles that Guillermo Torre holds in companies
Most Profitable Insider Trade
The most profitable trade made by Guillermo Torre
Guillermo Torre's Trading History
List of latest transactions for each holding click on a transaction to see Guillermo Torre's performance on stock
You May Also Like
Guillermo Torre insider profile FAQ
What is the percentage of profitable transactions made by Guillermo Torre?
The percentage of profitable transactions made by Guillermo Torre is 20%.
What is the average return per transaction made by Guillermo Torre?
The average return per transaction made by Guillermo Torre is -38.10%.
What stocks does Guillermo Torre hold?
Guillermo Torre holds: CRDL stocks.
What was Guillermo Torre’s latest transaction?
Guillermo Torre latest transaction was an Informative Buy of $21.72K.
What was Guillermo Torre's most profitable transaction?
Guillermo Torre’s most profitable transaction was an Informative Buy of CRDL stock on December 24, 2024. The return on the trade was 1.50%.
What is Guillermo Torre's role in Cardiol Therapeutics?
Guillermo Torre's role in Cardiol Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.